Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q1 Loss of 1c
Tweet Send to a FriendGet Alerts NBIX Hot Sheet
Price: $13.17 +3.62%
EPS Growth %: -1,700.0%
Financial Fact:
Total operating expenses: 13.71M
Today's EPS Names:
ANF, DXLG, FL, More
EPS Growth %: -1,700.0%
Financial Fact:
Total operating expenses: 13.71M
Today's EPS Names:
ANF, DXLG, FL, More
Trade NBIX Now!
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $11.3 million versus the consensus estimate of $10.84 million.
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
- Dollar Tree, Inc. (DLTR) Tops Q1 EPS by 2c; Issues Muted Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
